BioMarin Pharmaceutical(BMRN) - 2023 Q4 - Earnings Call Transcript

BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET Company Participants Traci McCarty - Head of Investor Relations Alexander Hardy - President and Chief Executive Officer Henry Fuchs - President, Worldwide Research and Development Brian Mueller - Executive Vice President and Chief Financial Officer Jeffrey Ajer - Executive Vice President and Chief Commercial Officer Greg Guyer - Executive Vice President and Chief Technical Officer, Manufacturing and Tec ...